Endocrine therapy: defining the path of least resistance.

about

Endocrine therapy: defining the path of least resistance.

Item

http://www.wikidata.org/entity/Q42670599

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Endocrine therapy: defining the path of least resistance.

@en

Endocrine therapy: defining the path of least resistance.

@nl

type

Item

label

Endocrine therapy: defining the path of least resistance.

@en

Endocrine therapy: defining the path of least resistance.

@nl

prefLabel

Endocrine therapy: defining the path of least resistance.

@en

Endocrine therapy: defining the path of least resistance.

@nl

P1476

Endocrine therapy: defining the path of least resistance.

@en

P2093

Andrew Stone

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Musgrove

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective identification of tumorigenic breast cancer cells

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

Tumour stem cells and drug resistance

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties.

Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities.

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.

Breast cancer stem cells and their role in resistance to endocrine therapy.

PIK3CA mutation associates with improved outcome in breast cancer.

P2888

bcr3659

P304

101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1186/BCR3659

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274361327

http://www.w3.org/2001/XMLSchema#string

P6179

1033803846

http://www.w3.org/2001/XMLSchema#string

P698

25928145

http://www.w3.org/2001/XMLSchema#string

P932

4053240

http://www.w3.org/2001/XMLSchema#string